Derm Research, PLLC   Report issue

For profit Phase 2 Phase 4
Founded: Louisville KY United States (2005)

Organization Overview

First Clinical Trial
2006
NCT00302445
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

DermResearch, PLCC | Derm Research, PLLC | DermResearch, PLLC | Leon Kircik, M.D.

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Acne Vulgaris (Phase 4)

Coinfection (Phase 4)

Dermatitis (Phase 4)

Dermatitis, Atopic (Phase 4)

Eczema (Phase 4)

Herpes Labialis (Phase 2)

Hyperpigmentation (Phase 4)

Infections (Phase 4)

Neoplasm Metastasis (Phase 4)

Pruritus (Phase 4)

Psoriasis (Phase 4)

Rosacea (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 19
  • # of Trial APIs: 19